Skip to Main Content

Paper Details

Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site.
Nat Commun
1
2022
S245N, S245N glycosylation site, active site, human, influenza, influenza A, neuraminidase, neuraminidase active site
Author NameAffiliation
Harm van BakelIcahn School of Medicine at Mount Sinai
Harm van BakelIcahn Genomics Institute, Icahn School of Medicine at Mount Sinai
Harm van BakelIcahn School of Medicine at Mount Sinai
Harm van BakelIcahn Genomics Institute, Icahn School of Medicine at Mount Sinai
Viviana SimonIcahn School of Medicine at Mount Sinai
Viviana SimonGlobal Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Viviana SimonIcahn School of Medicine at Mount Sinai
Viviana SimonCenter for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai
Viviana SimonIcahn School of Medicine at Mount Sinai
Ian A WilsonThe Scripps Research Institute
Ian A WilsonThe Skaggs Institute for Chemical Biology, The Scripps Research Institute
  • 1 - 11

Datasets

Release 1.2